Timothy Lu 4
4 · DICE Therapeutics, Inc. · Filed Apr 19, 2022
Insider Transaction Report
Form 4
Timothy Lu
CMO
Transactions
- Award
Stock Option (right to buy)
2022-04-14+157,756→ 157,756 totalExercise: $19.64Exp: 2032-04-14→ Common Stock (157,756 underlying)
Footnotes (1)
- [F1]The option vests as to 1/48th of the total shares monthly, beginning January 1, 2022, until such time as the option is 100% vested on the four-year anniversary, subject to the Reporting Holder's continued service to the Registrant.